Summary

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● The group usually releases upbeat results with huge surprise rates.

● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 42.95.

● The stock is close to a major daily resistance at EUR 42.35, which should be gotten rid of so as to gain new appreciation potential.

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● With an enterprise value anticipated at 5.89 times the sales for the current fiscal year, the company turns out to be overvalued.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 112.62 times its estimated earnings per share for the ongoing year.

● The company is not the most generous with respect to shareholders' compensation.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the past year, analysts have significantly revised downwards their profit estimates.

● Most analysts recommend that the stock should be sold or reduced.

● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.